Nvidia is Leading These Super Hot Stocks Now
Semiconductor company NVIDIA Corporation (NASDAQ:NVDA) beat expectations for the first quarter, reporting stronger than projected revenues of $924.9 million. Analysts expected to see sales coming in at $916.17 million. NVIDIA anticipates revenues for Q2 in the $990 million to $1.05 billion range, higher than the $976.20 million projected by analysts. The company reported that sales for the first three months of the year were negatively affected by its inability to meet the high demand for its chips. In addition, margins were dented with the shift to NVIDIA’s mainstream graphics business from its newest Kepler graphics processors. Gross margins fell year-over-year to 50.1% from 50.4% in 2011. Shares of NVIDIA are trading 8.29% higher today.
Don’t Miss: Here’s Why Molycorp Is In the Gutter.
Audience Inc. (NASDAQ:ADNC), manufacturer of audio chips for the mobile device market including Apple’s iPhone, is selling 5 million shares of stock as part of its initial public offering. Shareholders will be selling off the balance. JPMorgan Securities, Credit Suisse, and Deutsche Bank are the joint bookrunners for the offering, with Pacific Crest Securities acting as the co-manager. Shares of Audience are trading 2.04% higher today.
Nordstrom, Inc. (NYSE:JWN), which missed the mark in a dimmer-than-expected Q1 report, will retain its Buy rating with Goldman Sachs. Goldman held the rating despite lowering earnings estimates for the retailer. According to analyst Adrianna Shapira, Nordstrom’s could have potential gains off of successful Nordstrom investments. Nordstrom shares took a hit, trading 2.58% lower today.
Meanwhile, the quarter was a little brighter for another department store chain. Dillard’s, Inc. (NYSE:DDS) reported earnings per share for Q1 of $1.89, beating the analyst prediction of $1.67. Sales for the period also beat predictions, with revenue of $1.55 billion, versus the expected $1.53 billion. The retailer attributes these numbers to robust sales in the ladies’ accessories and lingerie departments, followed by shoes, men’s apparel and accessories, and cosmetics. However, consolidated gross margin for Q1 dipped to 38.4 percent from 38.8 percent in 2011. Shares of Dillard’s are trading 7.95% higher today.
Orexigen Therapeutics, Inc. (NASDAQ:OREX) reported that it is on track to a trial for its diet drug Contrave, Phase 2 clinical trials for its other weight loss drug, Empatic, have been completed. Shares of Orexigen are up 8.06% today.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.
Don’t Miss: Do Eric Sprott and China Still Believe in Gold?